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The CYP-P450 3A4 enzyme is responsible for metaboliz-
ing 50% of marketed drugs, covering a wide space of struc-
tural diversity [1]. From a drug discovery standpoint,
knowledge of ligand regional propensity to metabolism is
essential.
Experimental metabolite characterization is done using
liquid chromatography/tandem mass spectrometry [2].
While accurate, this technique is time consuming and
labor intensive. This is unfeasible for high throughput
testing of molecules under development early in the drug
discovery process. What is needed is a quick, accurate,
interpretable technique for identifying ligand regioselec-
tivity to metabolism by the 3A4 isozyme. A number of in
silico methods have been reported upon CYP 3A4 site of
metabolism prediction. These methods revolve around
one of two metrics: a ligand based QSAR analysis [3], or
fingerprint based molecular docking and scoring [4].
In the present method, topologically distinct regions of a
ligand are identified and ranked as putative metabolic
sites. Ranking is performed on the basis of 1) easily calcu-
lable electronic properties of each unique region and 2)
spacial and steric scoring based upon a constrained rapid
dynamics simulation. The electronic property based com-
ponent of this methodology has already been reported
and was found to be 71% accurate in the absence of the
rapid simulation component [5]. The final combined
method can be used as a reliable metric for evaluating
metabolic liability of lead compounds.
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